Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Wuhan Optics Valley Zhongyuan Pharmaceutical Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio involves 1 distinct examiner and 1 distinct art unit. The concentration within 1 distinct art unit indicates that the company's pharmaceutical technology is being reviewed by a specific technical division. This single-unit focus applies to the 1 pending office action currently active for the portfolio.
Tracy Ann Vivlemore is the busiest examiner, handling the 1 pending office action. This action is the only one of the 1 pending office actions currently active. As the only one of the 1 distinct examiners involved, Tracy Ann Vivlemore has sole responsibility for the company's current pending matter. The 1 busiest examiner pending action managed by this examiner represents the total prosecution activity for the company.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18401238 | OFF-THE-SHELF HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS AND PREPARATION METHOD AND USE THEREOF | VIVLEMORE, TRACY ANN | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18401238 | OFF-THE-SHELF HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS AND PREPARATION METHOD AND USE THEREOF | VIVLEMORE, TRACY ANN | 1638 | §101§102§103 | Non-Final OA | — | Pending | Dec 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial